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Abstract: With increasing life expectancy, demands for dental tissue and whole-tooth regeneration 
are becoming more significant. Despite great progress in medicine, including regenerative 
therapies, the complex structure of dental tissues introduces several challenges to the field of 
regenerative dentistry. Interdisciplinary efforts from cellular biologists, material scientists, and 
clinical odontologists are being made to establish strategies and find the solutions for dental tissue 
regeneration and/or whole-tooth regeneration. In recent years, many significant discoveries were 
done regarding signaling pathways and factors shaping calcified tissue genesis, including those of 
tooth. Novel biocompatible scaffolds and polymer-based drug release systems are under 
development and may soon result in clinically applicable biomaterials with the potential to 
modulate signaling cascades involved in dental tissue genesis and regeneration. Approaches for 
whole-tooth regeneration utilizing adult stem cells, induced pluripotent stem cells, or tooth germ 
cells transplantation are emerging as promising alternatives to overcome existing in vitro tissue 
generation hurdles. In this interdisciplinary review, most recent advances in cellular signaling 
guiding dental tissue genesis, novel functionalized scaffolds and drug release material, various 
odontogenic cell sources, and methods for tooth regeneration are discussed thus providing a multi-
faceted, up-to-date, and illustrative overview on the tooth regeneration matter, alongside hints for 
future directions in the challenging field of regenerative dentistry. 
Keywords: dentogenesis; amelogenesis; dentinogenesis; cementogenesis; drug release materials; 
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1. Introduction 
Dental injuries and diseases such as caries and periodontitis are affecting significant fractions of 
populations worldwide and are the main reason for dental tissue regeneration efforts [1,2]. Caries 
lesions cause local enamel resorption and dentin damage due to oral microbiota activities in the 
morbid tooth. Although relatively easily manageable at early stages, if left untreated caries causes 
excessive dentin damage and poses a need for reparative treatment [3]. Periodontitis is a complex 
inflammatory disease, where pathogenic oral microbiota and host immune response dysregulation 
lead to the gingiva, periodontal ligament, cementum, and alveolar bone damage [4]. Excessive 
periodontitis damage cannot be regenerated naturally, thus requires specialized soft and hard 
calcified tissues regeneration approaches. Next to infectious/inflammatory oral diseases, several 
heritable disorders of dental tissue formation exist (e.g., amelogenesis imperfecta, dentinogenesis 
imperfecta, and tooth agenesis), which affect tooth formation, eruption, calcification, or maturation 
[5–8]. In addition to disrupted teeth integrity, dental diseases often create an unaesthetically looking 
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oral cavity, thus affecting patients emotionally, which makes dental tissues regeneration critical in 
both aspects: health and aesthetics. 
Dental tissues have no or very limited capacity for self-regeneration [2,3,9,10]. Specifically, 
enamel becomes acellular after it is formed; dentin regeneration is limited and dependent on the 
dental pulp stem cell pool, which deteriorates in the case of an infection and inflammation; and 
cementum has no remodeling capacity and limited regrowth in the case of disease-induced 
resorption [10–13]. Each dental tissue contains a defined amount of inorganic matter (hydroxyapatite 
crystals), matrix proteins arranged in a scaffolding network, and microstructures such as lacunae in 
cellular cementum and microchannels, which accommodate cellular processes in dentin and 
cementum. The complex microarchitecture of the tooth poses a need for appropriate replacement 
materials, which have to be biocompatible and wear-resistant [14]. Additionally, the development of 
enamel and dentin relies heavily on mesenchymal–epithelial interactions, thus making it challenging 
to recapitulate the process in vitro even using existing odontogenic cell lines and adult stem cell 
culture methods [10,12,15–17]. Although a lot is already known about tooth formation and molecular 
cues shaping this process [5,6,18], signaling patterns involved in dental tissue differentiation in vitro, 
postnatal calcified tissue metabolism and regeneration are being actively studied and more research 
is expected in the future [18–47]. 
Efforts in whole tooth regeneration have been made for decades [48] and include biological, 
bioengineering, and genetic approaches. Revitalizing the odontogenic potency of the successional 
dental lamina (SDL) rudiment for lost tooth regeneration might be one possibility to induce tooth 
formation in vivo in the adult [49]. Whole-tooth restoration using autologous tooth germ cells and 
bioengineered tooth germ transplantation is another promising opportunity [50,51]. However, due 
to limited sources of tooth germ cells, the risk for immune rejection of allogeneic or xenogeneic cells, 
as well as ethical and legal constraints, adult stem cells of various sources or induced pluripotent 
stem cells (iPSCs) may be used instead [52–54]. Recently, combining cells of mesenchymal and 
epithelial origin of various plasticity is being actively explored for tooth regeneration using novel 
culture methods [55–57].  
Although the implantation of recombined embryonic or adult cells may give rise to tooth-like 
organs in vivo, the combination with scaffold material may improve tooth formation. Scaffolds can 
influence the biological behavior of cells and can give mechanical support to tissue constructs. Their 
consecutive degradation should parallel the formation of the native extracellular matrix and promote 
the assimilation of constructs after implantation [58]. In contrast to periodontal bone and other bone 
grafts, where numerous scaffold compounds have been developed and tested within the last decade 
[59–64], studies on artificial scaffolds for tooth regeneration are still rare due to the rather complex 
nature of teeth [14,65]. Recent studies in biomaterial development involve hybrids and composites of 
inorganic/organic components to be used as scaffolds to mimic the complex composition of the 
natural tooth [55,58,66]. New investigations have shown also that the functionalization of scaffolds 
using cell-free methods is possible. Vesicles, small RNAs, or exosomes from cultured stem cells or 
embryonic cells can be used onto or within scaffold material to address regenerative functions [65]. 
Besides, scaffolds can be loaded with drugs, growth factors, and/or receptor ligands to guide the stem 
cell differentiation process during dentogenesis [19,64,67,68]. However, very few artificial materials 
have been tested thus far in clinical trials [9,69]. 
In this review, the most recent discoveries regarding cellular signals guiding dental tissue 
differentiation in vitro and in vivo are summarized. Current developments of biocompatible 
functionalized scaffolds, drug-release materials, and their applications are addressed as well. Finally, 
whole-tooth generation approaches using various cellular sources and dilemmas in tooth 
regeneration are elucidated. An interdisciplinary approach is taken to cover tooth regeneration issues 
from molecular, via structural to biological aspects. 
2. Hard Dental Tissues and Their Genesis 
2.1. The Complexity of Dental Tissues 
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The process of teeth formation starts within embryogenesis and proceeds in multiple phases 
throughout the prenatal period, childhood and adolescence resulting in an eruption of permanent 
teeth. Each dental tissue forms in a unique way and in a tightly regulated manner, where one tissue 
is guiding or supporting the formation of the other [11,30,40]. Early odontogenesis is characterized 
by an epithelial–mesenchymal interaction, which is also a blueprint for the formation of other organs 
such as hair follicles or exocrine glands [70]. The epithelium is derived from the embryonic 
endoderm, while the mesenchyme is derived from the cranial neural crest. Placodal thickenings of 
the oral epithelium along the dental lamina first induce a cellular condensation of the underlying 
mesenchyme. The tooth primordium then undergoes different morphological stages forming a bud, 
cap, and later bell stage. While the epithelium gives rise to enamel, the mesenchyme is the source of 
the later pulp, periodontal apparatus and hard substances such as dentine and cementum. Then, 
epithelial components lose their inductive odontogenic competence while a reciprocal induction 
starts from the mesenchyme. These reciprocal crosstalks are governed by a signaling program 
consisting of a large number of molecules interacting in signaling pathways. Major examples of these 
factors are families such as the Bone Morphogenic Proteins (BMPs), Fibroblast Growth Factors 
(FGFs), Wingless/Int1 (Wnt), Hedgehog (Hh), or Ectodysplasin (EDA) functioning as morphogenetic 
inducers [18,65,71]. The morphogenesis is driven by signaling centers, which orchestrate tissue 
interactions and are involved in the size and shaping of the single tooth. In addition to cellular 
signaling, tissue forces, e.g., through an epithelial contraction, mesenchymal condensation, or bone 
biomechanics, participate in the formation of tooth morphology [71,72]. 
During tooth development, several stem cell niches have been identified. Epithelial stem cells 
are located, e.g., in the cervical loop, which is the apical end of the advancing epithelium consisting 
of an outer and inner layer and active until the onset of tooth root formation. These stem cells play a 
role in continuously growing teeth, e.g., mouse incisors. The elongation of the cervical loop as a 
double-layered structure is named Hertwig’s epithelial root sheath and is the signaling center for 
tooth root formation. It should also be mentioned that tooth formation depends on the interaction 
with the developing alveolar bone, which therefore should be considered in strategies for whole tooth 
regeneration [71,73].  
The mature tooth is a complex organ consisting of non-vascularized hard tissues: enamel, dentin, 
and a soft vascularized innervated dental pulp. The dental pulp is closely associated with dentin and 
harbors odontoblasts, dental pulp stem cells (DPSCs), pericytes, and other cellular populations. Blood 
vessels penetrating the pulp nourish the resident cells, while nerves participate in the sensory 
information exchange between the pulp and oral environment (Figure 1B). In the case of excessive 
dental injury (e.g., deep caries), odontoblasts, their precursors, and DPCSs can be recruited from the 
dental pulp and participate in dentin repair [74]. The tooth is surrounded by the periodontal 
ligament, which is a complex attachment tissue harboring odontogenic stem cells [69,75], linking the 
tooth to the alveolar jawbone (Figure 1). The mature molar tooth macrostructure and microstructures 
of dental tissues containing cell niches are depicted in Figure 1.  
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Figure 1. Tooth structure and dental tissues with the respective stem cell populations. (A) The 
odontoblast niche is bordering dental pulp beneath the dentin with odontoblast processes projecting 
towards enamel. (B) Diverse cell populations are found in dental pulp, DPSCs, which can give rise to 
odontoblasts. (C) Cementocytes are residing in the lacunae of cellular cementum at the root apex with 
their cellular processes projecting towards the periodontal ligament. 
2.2. Signaling Pathways Modulating Hard Dental Tissue Generation 
Many signaling cascades such as FGF, sonic hedgehog (Shh), transforming growth factors beta 
(TGF-β), BMPs, and Wnt/β-catenin are involved in the regulation of dentogenesis during 
development and adulthood [11,45,76–78]. Specific functions elicited by activation of these pathways 
are noted during distinct phases of dental tissue differentiation, some of which are beneficial for cell 
stemness and proliferation (FGF, Shh) while others such as Wnt, TGF-β, and BMPs act in postnatal 
differentiation phases and promote polarization, migration, and calcification [23,25–
28,30,31,37,77,79,80]. Next to this, purinergic signaling function is gaining research attention in dental 
tissues metabolism [32,81,82]. Most ligands activate transcription factors such as runt-related 
transcription factor 2 (Runx2), osterix (Osx or Sp7), and extracellular signal-regulated kinase 1/2 
(ERK1/2 or MEK1/2), which are central regulators of gene sets crucial for calcified tissues [33–35,83]. 
Epithelial–mesenchymal interactions are also involved in odontogenic and cementogenic 
differentiation [23,24,30,38,39]. 
2.2.1. Amelogenesis  
Tooth enamel formation or amelogenesis is the process of tooth enamel generation by 
ameloblasts, during which ameloblasts move towards the enamel surface and secrete proteins such 
as amelogenin, ameloblastin, and enameling. These proteins serve as scaffolds for calcium and 
phosphorus ions to be deposited on, thus guiding hydroxyapatite crystals aggregates—the enamel 
rods—generation. In this process, amelogenin and amelotin phosphorylation appears to be essential 
for correct enamel rod formation/organization [84–86]. The scaffolds are later degraded by matrix 
proteases and ameloblasts undergo apoptosis, which makes enamel the most mineralized acellular 
tissue in the human body, consisting of 95% hydroxyapatite crystals and 5% organic matter and water 
by weight [10,11]. Enamel is subjected to wear and tear throughout life. However, unlike other 
mineralized tissues of the human body, enamel cannot be regenerated due to its acellular nature. 
Although several cell sources were shown to have amelogenic capacity including keratinocyte stem 
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cells, epithelial cell rests of Malassez (ERM) from periodontal ligament, odontogenic oral epithelial 
stem cells (OEpSCs), adipose tissue-derived mesenchymal stem cells (AT-MSCs), and iPSCs [87–92]. 
Since ameloblasts undergo apoptosis upon fulfilling their function of enamel production, studies 
of amelogenesis rely on in vitro models such as murine immortalized ameloblast-lineage cell (ALC) 
line [15], organotypic cultures, or rodent models. Many discoveries regarding ligands, their 
downstream transcriptional factors and responsive genes expressing core enamel proteins and matrix 
metalloproteinases were done using the mentioned ALC line. Shh, which is one of the major ligands 
expressed in the enamel knot during tooth morphogenesis, was shown to have a direct effect on the 
expression of the major enamel matrix proteins amelogenin and ameloblastin. The upregulation of 
these proteins is mediated by an activated glioma-associated transcription factor (Gli1) in the 
presence of Shh [42,77]. Notably, Gli1 was proposed as a marker for selecting stem cells with the 
odontogenic potential for tooth regeneration [93,94]. Runx2 together with odontogenic ameloblast-
associated protein (ODAM) regulates matrix metalloproteinase 20 (MMP20) expression, the key 
enamel matrix-degrading enzyme [43], and has an affinity for the Wdr72 (gene coding for maturation-
stage ameloblast-specific protein) promoter [44]. WDR72 is an intracellular protein abundant in 
ameloblasts during enamel maturation with a proposed function in amelogenin endocytosis [20].  
Studies in dental organotypic cultures and transgenic mice also point out the importance of the 
mentioned pathways in dentogenesis. For example, Shh in combination with FGF8 was recognized 
as a stemness promoting ligans for ameloblast precursors (human skin fibroblasts) in a human-mouse 
chimeric tooth [87], while Runx2 was shown to have an affinity for the amelotin promoter and 
regulates its expression during the enamel maturation stage [95]. Regarding amelogenin turnover, a 
novel role of cytoplasmatic B-cell CLL/lymphoma 9 protein (Bcl9), its paralog B-cell lymphoma 9-like 
protein (Blc9l) and interaction partners Pygopus 1/2 (Pygo1/2) is proposed to play a role in 
amelogenin secretion [96]. 
Timely expression of β-catenin in dental tissues shapes tooth development by modulating 
various developmental signaling pathways, leading to the proper tooth number and morphology 
[45]. It was demonstrated in vitro that the β-catenin pathway, which is regulated by Wnt ligands, is 
involved in ameloblast polarity and motility [97]. Overactivation of the β-catenin pathway in the 
dental epithelium during the earliest stages of tooth development results in hyperdontia, and 
ablation—in tooth agenesis [98]—while, if overactive in postnatal ameloblasts, it causes poorly 
structured, softened enamel and its delayed formation [46]. Additionally, β-catenin overactivation 
downregulates enamel matrix metalloproteinases MMP20 and kallikrein 4 (Klk4), which are 
important in the removal of scaffolding proteins from maturing enamel [46]. An important regulator 
of Wnt/β-catenin pathway activity in ameloblasts is glycogen synthase kinase 3 beta (GSK3β) [99]. 
TGF-β superfamily ligands such as BMPs and TGF-βs are regulating enamel structural genes 
and matrix metalloproteinases expression. MMP20 in turn regulates TGF-β isoforms activity [47,100]. 
All three TGF-β isoforms induce Klk4 expression, while TGF-β1 and β2 induce amelotin expression 
[47]. TFG-β1 regulates Runx2 and its downstream target Wrd72 gene [44]. Thus, it appears that TGF-
βs are key ligands involved in the regulation of enamel scaffolding protein removal and endocytosis 
during enamel mineralization. BMP knock-outs result in downregulated matrix proteins and 
metalloproteinase expressions. In detail, BMP2 knock-out reduced amelogenin, enamelin, MMP20, 
and Klk4 expression, similarly to double-knockout of BMP2 and -4, which resulted in a significant 
reduction of MMP20 and Klk4 in ameloblasts [21,22]. Metalloproteinase insufficiency is detrimental 
for the enamel structure since excessive protein content in enamel does not allow properly organized 
crystalline structure formation, making the enamel softer and less shear-resistant.  
From the above-reviewed studies, it is evident that timely regulation of ligands known to be 
important for cell stemness maintenance and calcified tissue metabolism are the keys to structurally 
and morphologically correct enamel formation. Enamel integrity depends on proper enamel 
scaffolding protein deposition, phosphorylation state, and timely cleavage, which allow ameloblast 
migration and crystals deposition in an organized oriented pattern. The summary of the major 
signaling pathways involved in amelogenesis is schematized in Figure 2A and pathways modulators 
listed in Table 1.  
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2.2.2. Dentinogenesis 
Dentin is an acellular calcified tissue consisting of 70% hydroxyapatite, 20% organic phase, and 
10% water by weight. Dentin formation is executed by odontoblasts (or dentinoblasts), which are 
cells of mesenchymal origin. During dentinogenesis, odontoblasts migrate towards dental pulp and 
deposit collagen types I, III, and V, proteoglycans, and other matrix proteins, which provide the 
nucleation base for hydroxyapatite crystals. Besides scaffold-mediated mineralization, minerals 
precipitation and cell-derived matrix vesicles-driven mineralization occur during various stages of 
dentinogenesis [12]. After dentin synthesis is complete, odontoblasts remain beneath it with tiny 
cellular projections called odontoblast processes protruding into the microscopic channels in the 
dentin (Figure 1A). These projections are involved in detecting environmental stimuli (pH, cytokines, 
inflammatory mediators, and other signaling molecules) by odontoblasts, which can be mobilized for 
dentin regeneration in a case of damage. Thus, dentin possesses a limited capacity for regeneration 
[5,12,71,76]. Therefore, finding the appropriate cell source and differentiation strategy for dentin 
regeneration is of crucial importance. Thus far, dental pulp stem cells (DPSCs), stem cells from human 
exfoliated deciduous teeth (SHEDs), AT-MSCs, bone marrow-derived MSCs (BM-MSCs), and iPSCs 
have been shown to have the dentinogenic potential [25,80,81,90,101–103]. 
Shh is secreted by an epithelial cell layer, the zone of amelogenesis initiation, and serves as a 
paracrine differentiation signal for odontogenic cells [23,30]. It is later secreted by dentinoblasts 
during dentinogenesis and dental pulp stem cells (DPSCs), suggesting its autocrine function in 
odontogenic differentiation and dental pulp stem cell niche maintenance [30]. Amelogenin, secreted 
by ameloblasts, also participates in odontogenic differentiation of DPSCs by upregulating dentin 
sialophosphoprotein (DSPP) and dentin matrix acidic phosphoprotein 1 (DMP1) expression via the 
ERK1/2 and p38 pathways [104]. A similar effect could be achieved by the application of leptin: DSPP 
and DMP1 expression and ERK1/2, p38, and c-Jun N-terminal kinase (JNK) phosphorylation levels 
were markedly increased in leptin-treated DPCs [25,105]. Moreover, leptin application in the induced 
pulp cavity in rats leads to increased dentin formation during reparative dentinogenesis [106]. 
FGF exerts a time-dependent effect on dental-pulp derived odontoblast precursors. Transient 
exposure to FGF2 during the proliferation phase is beneficial for odontogenesis while no such effect 
is achieved upon constitutive FGF application until the maturation phase. FGF2 induces DSPP and 
DMP1 expression, which is also mediated via ERK1/2 pathway activation. Moreover, the agonistic 
effect on BMP2 and Wnt signaling during early odontogenesis were noted in cells treated with FGF2 
[26,27]. 
BMP/TGF-β signaling is important during early odontogenesis, where it activates SMADs and 
regulates Msx-1/2 transcription factors expression, as well as in differentiated odontoblasts, for 
matrix gene expression [101,107–109]. BMP2 positively regulates odontogenic differentiation of stem 
cells from exfoliated deciduous teeth (SHEDs) by promoting the expression of DSPP, DMP1, and 
matrix extracellular phosphoglycoprotein (MEPE) [80]. BMP2 knock-out in dental mesenchyme 
results in dentin deposition and microstructure abnormalities indicating its pivotal non-redundant 
role in early dentinogenesis [28,107], while BMP2 together with BMP4 have redundant functions in 
mature odontoblasts where they regulate DSPP, DMP1, bone sialoprotein (BSP) and collagen type I 
alpha-1 (Col1a1) expression [108]. Smad4, the intracellular component downstream of BMP/TGF-β 
signaling, is also necessary for DSPP, Col1a1, and osteocalcin (OCN) expression and proper 
odontoblast maturation. If Smad4 is ablated, dentin formation is largely impaired and does not reach 
normal thickness in mice [29].  
Wnt ligands are involved in odontoblast differentiation from mesenchymal precursor cells 
during the early stages of tooth development and later regulate dentin matrix deposition. It is 
proposed that at early stages of tooth development some Wnt ligands exert effects via the canonical 
Wnt/β-catenin signaling cascade and support odontoblast precursor cells stemness, while other Wnt 
ligands expressed at later developmental stages activate non-canonical pathways and promote the 
migration, proliferation, and mineralization of odontoblast precursors during dentinogenesis 
[31,83,110]. Experiments in vitro demonstrated that Wnt7b stimulates the expression of Runx2 and 
the key dentin matrix proteins DSPP, DMP1, and Col1a1 via ERK1/2-mediated activation during 
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dentinogenesis [83]. Wnt7b can activate canonical Wnt/β-catenin, but also the JNK cascade, thus 
promoting cellular migration and odontogenic differentiation [31]. Notably, activation of Wnt/β-
catenin signaling by inhibition of GSK3β is beneficial for reparative dentine formation during cavity 
repair [111]. 
Purinergic signaling mediated by adenosine receptors (P1 receptors, ARs) and purine receptors 
(P2X and P2Y) was also shown to play an important role in odontogenic differentiation of human 
DPSCs. P2 receptor activation by ATP promotes the expression of DSPP, DMP1 and mineralization 
of DPSCs via rapid phosphorylation of ERK1/2 [32]. Treatment of DPSCs with P1 receptor agonists 
in combination with ATP further improved odontogenesis by contributing to the upregulation of 
DSPP (mediated by A2BR and A3R) and DMP1 (via A1R and A2BR) and increased mineralization 
(via A1R and A2BR) [81]. Intracellular molecular events of P1 and P2 receptors agonistic action 
remain to be elucidated, but ERK1/2 is likely involved, at least partially, in the purinergic receptor-
mediated odontogenic differentiation of DPCs as is the case with several other differentiations 
regulated by purinergic signaling. 
Aside from the importance of activation of ERK1/2 and its downstream targets resulting in the 
expression of key dentin matrix genes, Tao and colleagues outlined Krüppel-like factor 4 (Klf4) as a 
major transcription factor regulating odontogenesis [33]. Klf4 induces TGF-β secretion, which 
together with BMPs positively regulates DMP1, the major dentin matrix protein expression. 
Moreover, Klf4 regulates odontogenesis-related gene expression temporally by interacting with 
histone deacetylase 3 (HDAC3) during early phases of odontoblastogenesis where it represses the 
expression of osterix and DSPP, while at later stages, when paired up with P300, it promotes their 
expression [33]. Osterix is a master-regulator of many structural genes of dentin and also of 
odontoblasts including DSPP, DMP1, nestin, and alkaline phosphatase (ALP) [34]. 
Studies regarding odontoblast differentiation outline the importance of signaling pathways and 
their interactions alike noted to be important for ameloblast differentiation with ERK1/2 being a 
convergence point for several signaling cascades involved in odontogenic differentiation of dental 
mesenchymal cells. Recently identified Klk-Osx transcriptional tandem, p38 and JNK are important 
in dentin structural genes regulation and odontoblast function (Figure 2B). Several dentinogenesis-
promoting molecules (listed in Table 1) were already tested in vivo and shown promising results. 
2.2.3. Cementogenesis  
Cementum, a thin calcified avascular tissue between dentin and periodontal ligament, is 
produced by cementoblasts. Cementum contains collagen type I, bone sialoprotein, osteopontin, 
glycoproteins and proteoglycans arranged in a fibrous network with hydroxyapatite deposits. 
Various types of cementum are present in distinct regions of mature tooth roots: thin acellular 
cementum is deposited around the cervical tooth area and below, while thick cementum with 
entrapped cementocytes and their processes penetrating cementum locates at the root apexes (Figure 
1C). Histological studies also indicate that a thin layer of dense acellular cementum lies beneath the 
cellular cementum at the root apex and plays an important role in cementum mineral metabolism. 
The cementum volume is enlarging over the lifespan and is not subjected to remodeling such as 
bones. Cementoblast precursors are present in the periodontal ligament and can be mobilized for 
cementum regeneration if needed [13,41,112]. Ex vivo, cementoblasts can be generated from 
periodontal ligament stem cells (PDLSCs), dental follicle stem cells (DFSCs), and iPSCs [75,113,114]. 
By analogy with dentinogenesis, TGF-β, and BMPs, Wnt and ameloblast-derived factors regulate 
cementum structural matrix protein expression. The central transcription factor of cementogenesis is 
Osx, which is activated by Wnt and TGF-β/BMP signaling. Osx is abundantly expressed in 
cementoblasts and cementocytes during cementum deposition, where it regulates DMP1, BSP, OCN, 
and ALP expression. It is proposed that Osx regulates cementogenic differentiation, while it inhibits 
cementoblast proliferation [35,115]. Stabilization of β-catenin leads to increased cementum formation 
via the upregulation of Osx, which is achieved by β-catenin binding to the Osx promoter, thus 
pointing to the direct regulation of Osx by β-catenin [36]. Additionally, Osx regulates the expression 
of dickkopf-related protein 1 (DKK1), an antagonist of β-catenin, and the transcription factors T-cell 
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factor 1 (Tcf1) and lymphoid enhancer-binding factor 1 (Lef1), which together with β-catenin form a 
transcription initiation complex with β-catenin in the cell nucleus. It is therefore evident that cross-
regulation of β-catenin and Osx plays a central role in cementogenesis [36,115].  
In addition to Wnt/β-catenin regulation, Osx is regulated via the TGF-β/Smad axis, as Smad3 
plays an important role in Osx gene expression during cementogenesis [37]. BMP2 and -4 likewise 
regulate Osx expression via a BMP-Smad-Runx2 cascade, but also Runx2-independently [34]. Despite 
the suggested beneficial role of Wnt/β-catenin in cementogenesis, another point of view has been 
expressed, according to which excess Wnt may inhibit cementogenesis under normoxic conditions, 
while hypoxia reverses this effect [24]. BMP2/4 signaling, which promotes cementogenesis in several 
ways, is negatively regulated by FGF2 in a concentration-dependent manner. This has been shown 
in periodontal ligament cells undergoing cementogenesis, thus implying that FGF2 is not beneficial 
for differentiation, but is important for cellular stemness [75]. This is in line with similar results in 
amelogenesis or very early stages of odontogenic differentiation [27,75,87]. Contrarily, in vivo, local 
FGF2 infusion was shown to promote cementum formation during periodontal injury regeneration 
by recruiting, enhancing and accelerating the proliferation of endogenous cemento/ostogenic cells 
[116]. 
The enamel-derived signaling components, amelogenin and its alternatively-spliced isoforms, 
regulate cementogenesis by modulating the expression of various matrix proteins. Full-length 
amelogenin application induced the expression of osteopontin (OPN), cementum attachment protein 
(CAP), OCN, Cola1, BSP, DMP1, and ALP mRNA; upregulated OPN and Col1a1 proteins; and 
improved the mineralization of an immortalized mouse cementoblast cell line (OCCM-30). Moreover, 
amelogenin positively regulated its putative receptor lysosome-associated membrane glycoprotein 1 
(LAMP1) in murine dental follicle cells and OCCM-30 cells, thus confirming its role as an important 
ligand regulating cementogenesis [38,39]. Amelogenin derivates, such as leucine-rich amelogenin 
peptide (LRAP), modulate gene expression in a slightly different manner: LRAP inhibited OCN 
expression, while promoted OPN and osteoprotegerin (OPG) expression in a dose-dependent 
manner and had a negative effect on cementoblast mineralization. The effects are probably mediated 
through the ERK1/2 pathway since ERK inhibition annuls the LRAP effects [79].  
Similar to dentin and dentinogenesis, cementogenesis has a central transcription factor: Osx, 
which regulates cementogenesis-specific gene expression. Besides Osx, Runx2, and ERK1/2 are 
involved in cementogenic differentiation. In addition, ameloblast-derived proteins are important 
ligands positively regulating cementum matrix-associated gene expression (Figure 2C). Modulators 
of herein discussed cementogenic pathways are listed in Table 1.  
Gained knowledge about molecular cues shaping dental tissue genesis may help to establish 
novel stem cell selection, culture, and differentiation methods and develop functionalized scaffolds 
and biomaterials, which will support and promote amelogenic, dentinogenic, and cementogenic 
differentiation in vitro. Thus, it will approximate the era of dental tissues regeneration using most 
suitable odontogenic cells with adequately functionalized biomaterials.  
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Figure 2. Major signaling cascades involved in amelogenesis, odontogenesis, and cementogenesis. (A) 
Signaling pathways modulating amelogenesis with TGF-β superfamily ligands (BMP2 and TGF-
β1/2/3) playing the major role in matrix protein and metalloproteinases feedback-regulation and 
Runx2 being an important transcription factor. (B) Central signaling cascades of odontogenesis are 
depicted. The TGF-β superfamily ligands (BMP2/4 and TGFβs) regulate many odontogenic genes 
with ERK1/2 as convergence point and Klk4-Osx as important transcription factor tandem. (C) Major 
cementogenesis-related signaling cascades with Osx as the central transcription factor being regulated 
via Wnt/β-catenin in a feedback-loop. Ameloblast-derived products (LRAP and amelogenin) were 
shown modulate key cementogenic gene expression in vitro. 
Table 1. Cell Sources and signaling modulators useful for amelogenesis, dentinogenesis, and 
cementogenesis. 
Tissue 
Plausible Cell 
Sources 
Signaling 
Pathway/Node 
Interfering Molecule(s) 
Stimulatory Inhibitory 
E
n
am
el
 
Keratinocyte stem 
cells [87]; 
ERM from 
periodontal 
ligament [88]; 
Hh 
Shh [42]; purmorphamine 
[118] a 
cyclopamine [118] a 
FGF FGF8 [87], FGF10 [118] a 
pan-FGF receptor 
inhibitor SU5402 
[118] a 
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OEpSCs [89]; 
AT-MSCs [90]; 
iPSCs [91,92,117] 
Wnt/β-catenin 
6-Bromoindirubin-3′-oxime 
(BIO) (GSK3βi) [45] 
GSK3β [99], ICG-001 
[97] 
BMP BMP2/4 [21,22] b 
Noggin (BMP4i) 
[117] 
TGFβ TGF-β1,2,3 [47,100] SMAD7 [119]a 
D
en
ti
n
 
DPSCs 
[25,81,101,102]; 
SHEDs [80]; 
AT-MSCS [102]; 
iPSCs [103] 
Hh 
Shh [23], purmorphamine 
[120] 
_ 
FGF FGF2 [26,27,120] 
PD173074 (FGFR1i) 
[120] 
Wnt/β-catenin 
BIO, CHIR, Tideglusib 
(GSK3bi) [111,121] b, Wnt7b 
[83]; 
XAV939 (tankyrasei) 
[31,101], rhDKK1 
[101] 
BMP BMP2 [28,108] b, BMP4 [108] b 
Noggin, LDN193189 
[101] 
P2Rs 
ATP, ARL 67156 (ATPasei) 
[32] 
Suramin [32], iso-
PPADS tetrasodium 
salt [82] 
ERK1/2 Leptin [105] 
PD98059 (ERK1/2i) 
[105] 
ERK1/2 Amelogenin [104] 
U0126 (ERK1/2i) 
[104] 
C
em
en
tu
m
 
PDLSCs [75]; 
DFSCs [113]; 
iPSCs [114] 
Wnt/β-catenin LiCl, Wnt3a [35] DKK1 [35] 
FGF FGF2 [116] b _ 
BMP BMP2/4 [75] FGF2 [75] 
TGFβ rhTGFβ-1 [78] SIS3 (Smad3i) [37] 
ERK1/2 Amelogenin [39], LRAP [79] U0126 (ERK1/2i) [79] 
a studies of epithelial invagination/development; b studies in vivo; the rest are cell culture-based 
reports. 
3. Scaffolds and Drug Release Materials for Tooth Regeneration 
3.1. Scaffolds for Enamel, Dentin, and Cementum Regeneration 
Scaffolds and biomaterials are essential components in dental tissue regeneration since they can 
be used as a template for tissue regeneration by serving as a site of attachment for the regenerative 
cells from the surrounding tissues or act as a delivery platform for implantable odontogenic cells with 
the ability to differentiate towards the desired cell type [122,123]. Additionally, the scaffold material 
may be used as a delivery platform for bioactive molecules such as drugs or proteins (especially 
growth factors) that further enhance the regenerative potential [60,61,63,124]. 
In general, scaffold materials used in tissue regeneration need to be readily available and meet 
criteria such as biocompatibility and biodegradability without any toxic metabolites. In the case of 
scaffolds for tooth regeneration, biomaterials are subjected to the challenging environment of the oral 
cavity—including mechanical forces due to mastication, the presence of microorganisms, and 
varying conditions regarding temperature and pH. The intended biomaterial has to face these 
challenges without limitations in its biocompatibility [125]. Since it is generally intended to mimic 
the native extracellular matrix by using biomaterials, properties besides biocompatibility are imposed 
by the tissue which should be regenerated. Thus, in the case of scaffold materials for dental tissue 
engineering, the used material systems differ greatly depending on whether enamel, endodontic, or 
periodontic tissue is intended to be regenerated. Categories for biomaterials used in tooth 
regeneration are natural organic, synthetic organic materials, or inorganic materials [126]. Natural 
organic materials involve peptides such as collagen or gelatin and polysaccharides such as chitosan, 
alginate, or agarose. Frequently used synthetic organic materials are poly(lactic acid) (PLA), 
poly(glycolic acid) (PGA), poly(lactic-co-glycolic acid) (PLGA), and poly(caprolactone) (PCL), while 
commonly used inorganic materials are bioactive glasses or calcium phosphates such as 
hydroxyapatite (HA), β-tricalcium phosphate (TCP), and cementitious systems of calcium phosphate 
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(CPC) or calcium silicate (e.g., mineral trioxide aggregate, MTA). Polymeric materials often lack 
mechanical and biological properties but are able to establish three-dimensional porous structures, 
thereby providing a highly hydrated matrix in vivo that facilitates the transport of nutrients, 
anabolites, and catabolites. In turn, inorganic biomaterials used in tissue engineering often comprise 
preferable biological properties but have disadvantages such as brittleness and lacking in the supply 
of nutrients. Thus, composite materials comprising both organic and inorganic constituents gain 
increasing interest in recent years due to their inherent combination of the desirable properties of the 
single components [127]. In the following subsection, the challenges, approaches, and recent studies 
for the targeted and scaffold-assisted regeneration of enamel, dentin, and cementum are presented. 
Injectable biomaterials are a central and highly desirable class in the context of dental regeneration, 
but are not extensively reviewed here due to the very recent and detailed publication of a distinct 
review on this topic by Haugen and coauthors [128]. 
3.1.1. Enamel Formation 
The main challenge in the regeneration of enamel is its acellular nature. Enamel forming 
ameloblasts go through apoptosis when amelogenesis is finalized and the in vitro culture of 
ameloblasts is yet unestablished in a scale needed for appropriate tissue regeneration [129]. 
Furthermore, although the synthesis of hydroxyapatites is widely investigated, attempts to model 
the unique assembling of HA-crystals in enamel were not yet successful [130]. Thus, many recently 
published studies follow a biomimetic approach by using amelogenin, peptide fragments of 
amelogenin, or various synthetic peptides as a template matrix to mimic the spatiotemporal 
environment for the deposition of enamel. 
Recently, Zheng et al. used a peptide consisting of eight repetitive sequences of aspartate-serine-
serine (8DSS) as a biomimetic template for enamel remineralization in an in vivo model. Their results 
indicate that 8DSS peptides serves as both inhibitor of further enamel demineralization and promoter 
of remineralization by entrapping calcium and phosphate from the surrounding medium. As a result, 
mineral density and enamel volume increased to a comparable extent as with a fluoride treatment 
[131]. Treating enamel surface with an elastin-like polypeptide (ELP) functionalized with glutamic 
acid residues to dissolve calcium and phosphate due to its acidic properties leads to a matrix 
consisting of ELP and amorphous calcium phosphate (ACP). After immersing the specimen in 
simulated oral fluid, a dense layer of highly orientated apatite nanorods is formed from the matrix 
with mechanical properties close to natural enamel and high chemical stability against acidic impacts 
[132]. The properties of poly(amidoamine) (PAMAM) dendrimers can be tailored by modification of 
their functional surface groups. Accordingly, the effect of amino-, carboxyl-, and alcohol-terminal 
groups has recently been studied in vitro. The results show that the electrostatic interactions between 
biomaterial and enamel surface affect the remineralization process. PAMAM-NH2, exhibiting 
interactions between pro-cationic amino groups and negatively charged enamel surface, shows the 
best results, followed by PAMAM-COOH due to interactions between carboxylate residues and 
calcium cations in hydroxyapatite, while neutral PAMAM-OH was not effective [133]. Additionally, 
Gao et al. evaluated the performance of amorphous calcium phosphate loaded PAMAM-dendrimers 
functionalized with an SN15 peptide sequence, which is known for its good adsorption on 
hydroxyapatite, for the use as adhesive in resin-based approaches of caries lesion treatments and 
achieved 90% higher remineralization compared to control [134]. 
3.1.2. Dentin Formation 
Dentin regeneration is most often related to a treatment of the dentin-pulp complex. Since pulp 
vitality is essential for tooth homeostasis and stability, strategies to maintain this vitality are highly 
desirable. Presently, pulp capping is the main therapy maintaining the pulp vitality but is frequently 
accompanied by irreversible pulp inflammation and reinfections [16]. Thus, innovative approaches 
and biomaterials for the regeneration of the pulp–dentin complex are highly desirable.  
In classical endodontic therapy via apexification, the pulp space is initially cleared and sealed 
with calcium hydroxide or MTA to induce a hard-tissue formation at the apical area that is used as a 
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barrier for a permanent root filling material. Since this procedure does not promote further root 
development, root canal walls remain thin and fragile, leading to teeth that are prone to further issues 
[135]. To overcome these limitations, regenerative endodontic therapies including revascularization 
are being developed. Here, bleeding is induced to fill the endodontic canal and form an autologous 
blood clot that serves as a scaffold homing matrix proteins, (stem) cells, and growth factors, which 
consequently leads to the regeneration of the pulp–dentin complex due to root development, apical 
closure, and maintenance of the tooth vitality [17,136]. However, due to the presence of mesenchymal 
stem cells in the infiltrating blood, the generated tissue is more bone-like mixed with connective 
tissue instead of the desired pulp–dentin complex [137]. 
Recently, Mandakhbayar and colleagues used strontium-free and strontium-containing 
nanobioactive glass cement in a pulp capping approach to evaluate their potential to regenerate the 
pulp–dentin complex in vitro and in vivo [138]. The nanobiocement based on mesoporous calcium 
silicate nanobioactive glasses showed a fast release of Ca-, Sr-, and Si-ions, which are known for their 
bioactive properties in hard-tissue regeneration; promoted the odontogenesis of DPSCs in vitro; and 
showed promising results in vivo, especially for Sr-containing biomaterials [138]. Boron-modified 
bioactive glass nanoparticles were embedded in an organic matrix of cellulose acetate, oxidized 
pullulan, and gelatin by Moonesi-Rad and associates to build a dentin-like construct by freeze-drying 
and subsequent mold pressing [139]. The composite material induced the enhanced deposition of a 
calcium phosphate layer after immersion in simulated body fluid. Moreover, cell culture studies 
using DPSCs indicated the promotive effects of boron-modified bioactive glasses on attachment, 
migration, and odontogenic differentiation [139]. In a classical ternary system comprising an 
injectable collagen scaffold, DPSCs, and growth factors, Pankajakshan and coworkers evaluated the 
effect of mechanical properties of the collagen matrix [140]. Via concentric injection, the authors 
created a scaffold with an inner section of lower stiffness, which is covered with an outer section of 
higher stiffness to mimic the mechanical properties of the natural pulp–dentin complex. Additionally, 
they loaded the softer scaffold material with proangiogenetic vascular endothelial growth factor 
(VEGF) and the stiffer scaffold material with BMP2 to enhance the site-specific endothelial or 
odontogenetic differentiation of DPSCs, respectively. The results show that the stiffness of the 
materials regulates the direction of DPSCs differentiation. This effect is further enhanced by the 
loading of the collagen matrices with VEGF or BMP2, respectively [140]. 
3.1.3. Cementum Formation 
Cementum regeneration is closely related to the treatment of the periodontal complex comprised 
of alveolar bone, periodontal ligament, gingiva, and cementum (Figure 1). Besides the structural 
support a scaffold material provides to the affected tissue, scaffolds used for regeneration of the 
periodontal complex are often used as a delivery vehicle for various bioactive compounds such as 
proteins, growth factors, or gene vectors to favor the regenerative process and induce the recruitment 
and homing of endogenous stem cells from surrounding tissues. The development of 
multicompartment scaffolds aims to meet the diverse challenges of the different tissues to be 
regenerated in periodontal defects in a single scaffold [141]. Additionally, besides synthetic scaffolds, 
cell-based scaffolds such as cell sheets are part of current research. In this approach, cell types that 
are relevant for the periodontal regeneration are cultivated in vitro extensively, until strong cell–cell 
interactions are established and an extracellular matrix has formed, thus allowing transplantation of 
the cell sheet as a scaffold-like material [142]. 
Recently, Fakheran and peers evaluated the regenerative potential of Retro MTA, a calcium 
silicate cement, in combination with tricalcium phosphate in vivo and showed that newly formed 
bone and cementum was significantly higher than in the untreated control group. Moreover, the poor 
biodegradation rate of MTA is improved due to the combination with biodegradable TCP [143]. In a 
preclinical study to treat periodontal defects in dogs, Wei et al. used an inorganic calcium phosphate-
based scaffold material loaded with BMP2 [144]. The CaP-based biomaterial alone leads to a 
significantly increased regeneration of mineralized tissue as well as to an improved attachment of the 
teeth to the surrounding tissue compared to untreated control and a deproteinized bovine bone 
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mineral that serves as commercial control. When loaded with BMP2, these positive results could even 
be improved two- and three-fold regarding height and area of the remineralized tissues, respectively. 
Noteworthy, the encapsulated BMP2 had a greater impact on osteogenesis than on cementogenesis 
[144]. Following the multicompartment-scaffold approach, Wang and collaborators applied a 
bilayered material containing growth factors. The hybrid material containing an FGF2-loaded 
propylene-glycol alginate gel coating the root surface for ligament regeneration and a BMP2-loaded 
(PLGA)/calcium phosphate cement for periodontal regeneration was tested in vivo with non-human 
primates. Following a promising study in rodents, the authors reported significantly enhanced 
regeneration of cementum and periodontal ligament and a high vascularization of the newly formed 
periodontal ligament (PDL), thereby confirming the positive results of the previous study [145,146]. 
Vaquette el al. developed bilayered scaffold materials based on polycaprolactone and combined 
them with cell sheets: while a fibrous three-dimensional compartment with macropores should favor 
alveolar bone regeneration, a flexible porous membrane aims at delivering the cell sheet and 
regenerates the periodontal ligament [147]. In their study, the authors evaluated the in vivo 
regenerative potential of the hybrid materials with different cell types forming the cell sheet, namely 
gingival cells, periodontal ligament cells (PDLCs), and bone marrow-derived mesenchymal stem 
cells (BM-MSCs). Results from histomorphometry and micro-computed tomography (µ-CT) show 
that scaffolds containing BM-MSCs and PDLCs had greater regenerative potential due to superior 
new bone and cementum formation compared to the scaffolds containing gingival cell sheets. 
However, the regenerative potential of scaffolds containing BM-MSCs and PDLCs did not differ 
significantly compared to the performance of the non-cellularized control scaffold. Thus, the biphasic 
scaffold alone is also a promising candidate for further studies [147]. Table 2 summarizes recently 
published studies emphasizing regenerative approaches of enamel, dentin, and cementum. 
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Table 2. Compilation of recently published studies emphasizing regenerative approaches of enamel, dentin, and cementum. 
Tissue Scaffold Material Study Model Results Ref. 
E
n
a
m
e
l 
8DSS: Oligopeptide of eight repetitive 
sequences of aspartate-serine-serine 
In vivo model using Sprague-Dawley rats with 
induced caries. 
Increased remineralization by 8DSS due to 
inhibited enamel demineralization and 
promoted remineralization. 
[131] 
Elastin-like polypeptide functionalized 
with glutamic acid residues 
In vitro remineralization of bovine enamel 
specimens by pH cycling after immersion in 
biomaterial solution. 
Formation of a dense layer of highly 
orientated apatite nanorods with mechanical 
properties close to natural enamel and high 
chemical stability against acidic impacts. 
[132] 
PAMAM-dendrimers with varying 
terminal groups: -NH2, -COOH, -OH 
In vitro remineralization of bovine enamel 
specimens by pH cycling. 
Remineralization is affected by electrostatic 
interactions between scaffold and enamel 
surface. PAMAM-NH2 shows the best 
results, followed by PAMAM-COOH. 
[133] 
ACP-loaded PAMAM dendrimers 
functionalized with SN15 peptide 
sequence. 
In vitro enamel remineralization by cycling 
immersion in artificial saliva and 
demineralization solution. 
Evaluated biomaterial achieves 90% higher 
remineralization compared to control. 
[134] 
D
e
n
ti
n
 
Nanobioactive glass cements with or 
without Sr 
In vitro evaluation of biocompatibility and 
differentiation of DPSCs. In vivo evaluation 
using an ectopic odontogenesis model and a 
tooth defect model in rats. 
Fast release of bioactive Ca-, Sr- and Si-ions. 
Promotion of the odontogenic differentiation 
of DPSCs in vitro. 
More new dentin formation by Sr-containing 
biomaterial in vivo. 
[138] 
The organic matrix of cellulose acetate, 
oxidized pullulan and gelatin loaded 
with boron-modified bioactive glass 
nanoparticles. 
In vitro evaluation of biomineralization, 
biocompatibility, proliferation, and 
differentiation with hDPSCs. 
Boron-modified bioactive glass 
nanoparticles exhibit promotive effects on 
the deposition of a CaP as well as on 
adhesion, migration, and differentiation of 
hDPSCs. 
[139] 
Biphasic collagen matrix: Inner section 
of lower stiffness loaded with VEGF 
covered by an outer section of higher 
stiffness loaded with BMP2. 
In vitro evaluation using hDPSCs regarding 
biocompatibility, proliferation, and 
differentiation. 
The direction of DPSCs differentiation is 
regulated by material stiffness and amplified 
by the respective growth factor. 
[140] 
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C
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n
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m
 
retroMTA + tricalcium phosphate 
In vivo test using dehiscence periodontal 
defects in dogs. 
Significantly increased the new bone and 
cementum formation. The biodegradability 
of retroMTA is enhanced by adding TCP. 
[143] 
Calcium phosphate loaded with BMP2 
In vivo periodontitis model using critical-sized 
supra-alveolar defects in dogs. 
Significant increase in regeneration of 
mineralized tissues. Loading with BMP2 
leads to a further 2–3-fold increase. 
[144] 
Bilayered material: FGF2-
propyleneglycol alginate gel covered 
by BMP2-PLGA/CaP cement. 
In vivo test using three wall periodontal 
defects in non-human primates. 
Significantly enhanced regeneration of 
cementum and periodontal ligament. Newly 
formed PDL is highly vascularized. 
[145] 
PCL-based bilayered material: a 
flexible porous membrane delivers cell 
sheets and is covered by a fibrous and 
porous 3D compartment. 
In vivo test using dehiscence periodontal 
defects in sheep to evaluate the potential of 
different cell types forming the cell sheets: 
Gingival cells (GCs), PDLCs, and hBM-MSCs. 
Scaffolds containing BM-MSCs and PDLCs 
show superior new bone and cementum 
formation compared to scaffolds containing 
gingival cells. 
[147] 
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3.2. Drug Release Systems Useful in Tissue Engineering—To be Adapted to Tooth Engineering 
As discussed in the previous section, whole tooth regeneration is one of the most challenging 
fields in regenerative medicine—also regarding drug release aspects. In stem cell-based approaches, 
a cocktail of different drugs would be required to tightly tailor the differentiation of the 
corresponding cells involved in amelogenesis, dentinogenesis, and cementogenesis, respectively. 
This means that, besides appropriate scaffolds, compounds have to be developed for drug 
encapsulation and controlled release of those substances involved during tooth formation (such as 
growth factors and receptor ligands, as listed in Figure 2). Thus far, drug release approaches in tooth 
regeneration are mainly restricted to the delivery of antibiotics to avoid inflammation [66]. 
In analogy to other tissues and organs engineered using stem cell-based approaches, the drug 
delivery systems (DDS) are mainly classified into the following release mechanisms: diffusion 
through water-filled pores; diffusion through the polymer; osmotic pumping; and erosion [148]. In 
the past two decades, novel release materials have been designed and prepared that could be 
classified into the following three groups: (a) polymer-based systems; (b) ceramics-based systems; 
and (c) hybrid systems (e.g., organic/inorganic and polymer/ceramic) [62,149]. Many of them are 
prepared as nanomaterials (e.g., spheres, capsules, and rods) [64]. 
To develop a DDS that allows kinetically controlled release of drugs supporting the required 
stem cell differentiation processes, a variety of material characteristics would have to be considered. 
Parameters that influence the release behavior of polymer-based release materials include the 
following: molecular weight (number and weight average, respectively, Mn/Mw) and corresponding 
polydispersity index (PI), number and nature of end-groups, and the polymer morphology mainly 
determined by the monomer 3D structure (amorphous and crystalline/semi-crystalline with the 
degree of crystallinity). All of them are able to influence the size and shape, as well as density and 
porosity of the entire DDS that includes the encapsulated drugs. In addition, the active substance 
(drug) itself influences the release kinetics via interaction with the encapsulation material. Thus, the 
drug hydrophilicity/hydrophobicity (resulting from chemical composition, functional groups, 
hydrogen bonds, etc.) is one of the most limiting aspects, as well as its ability to act as surfactants or 
plasticizer which would interfere with the release mechanism. Huang et al. comprehensively 
reviewed the release mechanisms discovered within the last five years, including drugs for tooth 
regeneration [65]. Most recent developments include tunable conductive polymers to be used for 
controlled delivery [150]. As stated in Section 3.1, in tooth regeneration, drugs (such as growth factors 
and FGF-2) are usually simply added to the scaffold material—not yet encapsulated and released 
from tailored delivery materials [14,19,66,67,151–157]. Recently, Moon et al. reported a study using 
nitric oxide release to support the pulp–dentin regeneration [158]. However, in this case, release 
kinetics cannot be controlled or adjusted to the differentiation processes of the corresponding cells. 
Very few studies reported the application of specific drug encapsulation materials, mainly using 
hydrogels [63–65,159–161]. Hydrogels can easily be prepared using natural and artificial polymers 
(sometimes a combination of both classes). One of the most prominent groups of hydrogels is based 
on polysaccharides [149,162,163]. Furthermore, other polymers such as polyvinyl alcohol (PVA), 
polylactic acid and polyglycolic acid (PGA), polyacrylic acid (PAA), and polyethylene glycol (PEG) 
are intensively studied regarding their ability to form hydrogels used for controlled delivery 
[160,164]. Hydrogels offer various advantages; most importantly, they are tunable in their chemical 
structure resulting in controlled degradability. In a comprehensive review, Li et al. discussed various 
multiscale release kinetic mechanisms of hydrogels and classified them according to the structural 
interactions. Thus, the kinetics are significantly determined by the hydrogel mesh size, network 
degradation, swelling, and mechanical deformation. In addition, kinetics depend on various 
interactions of the hydrogel components such as conjugation, electrostatic interaction, and 
hydrophobic association [164].  
For hard tissue such as bone, our group could recently show that it is possible to guide 
osteogenesis via purinergic receptor ligand release. Osteogenesis of mesenchymal stem cells is 
influenced by various purinergic receptors (P1, P2X, and P2Y) [122,124,165–168]. Thus, a release of 
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specific agonists and/or antagonists enables tailoring of the corresponding receptor up- or 
downregulation. Furthermore, besides osteogenesis, purinergic receptors are also involved in 
angiogenesis—a process also required during tooth regeneration [68,169,170]. 
In a recently published paper, we reported the synthesis and testing of novel hybrid release 
materials based on hydroxyapatite and agarose used to improve the release kinetics of drugs applied 
for guided osteogenesis [171]. Scanning electron microscopy (SEM) revealed details regarding the 
influence of the drying treatment: lyophilized (LYO) versus supercritically-dried (SCD) gels were 
tested and compared. As shown in Figure 3, SEM confirmed a homogeneous distribution of the 
elements involved in the hybrid (carbon, calcium, and phosphorus). In addition to SEM, energy-
dispersive X-ray spectroscopy (EDX) results are given in [171]). 
 
Figure 3. SEM images of agarose lyophilized (LYO) (a–c) and supercritically-dried (SCD) (d–f) and 
agarose/hydroxyapatite (33/76 w%) composite LYO (g–i) and SCD (k–m) at three different 
magnifications. The scale bars are 10 µm (left), 1 µm (middle), and 0.2 µm (right), respectively. 
Reproduced from Witzler et al., 2019 [171]. Open Access Copyright Permission (Creative Commons 
CC BY license). 
Hitherto, hybrid systems are mainly studied as release materials for hard tissue regeneration 
[67]. Here, sustained delivery is required for guided stem cell differentiation, a burst release is 
favorable to achieve anti-inflammatory and antibacterial effects. Since both processes are also 
relevant in tooth formation, hybrid materials would be promising candidates to be investigated as 
release materials to improve cascades, as shown in Figure 2. In previous studies, the HA/agarose 
hybrids were loaded with model drug compounds for guided differentiation of MSCs. Different 
release kinetic models were evaluated for adenosine 5′-triphosphate (ATP) and suramin (Figure 4) 
[171]. Although both drugs are highly water-soluble, the release could be slowed to four days, which 
is significantly longer than comparable systems reported in the literature [172]. 
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Figure 4. Release data of (a) adenosin triphosphate (ATP) and (b) suramin from 
agarose/hydroxyapatite (AG100HA0) (black), AG50HA50 (orange), and AG33HA67 (blue) scaffolds. 
Data fit: Weibull equation. Reproduced from Witzler et al., 2019 [171]. Open Access Copyright 
Permission (Creative Commons CC BY license). 
Future efforts should be directed toward the development of tailored drug loading and/or 
encapsulation materials to be used for the controlled release of bioactive substances during tooth 
formation [157,173]. As shown in Figure 2 and Table 1, there are various signaling molecules and 
corresponding activators and suppressor molecules involved in the formation of enamel, dentin, and 
cementum. For a number of these substances, loading and controlled-release from non-cytotoxic 
materials already exist, as shown in Table 3. Release materials mainly consist of natural or artificial 
polymers, but also hybrids composed of organic and inorganic components. The focuses of the 
studies are release kinetics and corresponding mechanisms. However, some drugs are being 
successfully applied in vivo. 
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Table 3. Materials applicable for loading, encapsulation and drugs/signaling molecules release for promoting cell proliferation, and differentiation. 
Signaling Molecule 
Material for Drug Loading/Encapsulation 
and Release 
Application Release Efficiency/Kinetics Tested in Reference 
Amelogenin 
(EKR1/2 activator) 
Self-assembled nanogels of cholesterol-
bearing mannan as templates for 
hierarchical hybrid nanostructures 
Amelogenin-releasing hydrogel for 
remineralization of enamel damage 
(artificial caries) 
Cytotoxicity—in PDL fibroblasts; ex vivo 
enamel caries models of human molars 
[174] 
Purmorphamine (Hh 
activator/Smo 
agonist) 
Glutaraldehyde (GA)-crosslinked gelatin 
type B matrix (for small molecules and 
proteins release) 
In vitro delivery system for Wnt, Hh 
agonists and growth factors (e.g., FGF2, 
VEGF) beneficial for endochondral 
ossification 
Release kinetics (burst vs. sustained 
release) studied without using cell 
culture; released molecules bioactivity 
verified in cell culture/biological assays 
[175] 
Poly(propylene glycol–co-lactide) 
dimethacrylate (PPLM) adhesives for 
incorporating purmorphamine and TCP 
Cell attachment and response to 
photocured, degradable bone adhesives 
containing TCP and purmorphamine 
MC3T3-E1 (mouse pre-osteoblast cell line)  [176] 
PCL microspheres for encapsulating small 
molecules using a single emulsion oil-in-
water method 
Purmorphamine and retinoic acid-
loaded microspheres for prolonged 
release during neural differentiation 
Human iPSC aggregates differentiating 
into motor neurons 
[177] 
FGF 
D-RADA16 peptide hydrogels coated on 
artificial bone composed of nanohydroxy-
apatite/polyamide 66 (nHA/PA66) (for basic 
FGF release) 
Porous growth factor-releasing 
structure for treating large bone defects  
Female SD rat BM-MSCs; female SD rats 
with induced large bone defects 
[178] 
Acetyl chitosan (chitin) gel (for binding and 
release of chitin binding peptide-FGF2 
fusion protein) 
Lysozyme-responsive (dose-dependent 
or activity-dependent) release of CBP-
FGF2 
Studies without using cell 
culture/biological assays 
[179] 
Silk fibroin e-gel scaffolds (loaded with 
albumin = Fe3O4-bFGF conjugate) 
Enhancing alkaline phosphatase, 
calcium deposition, and collagen 
synthesis during osteogenic 
differentiation  
SaOS-2, osteogenic differentiation [180] 
BIO (Wnt/β-catenin 
activator) 
Polymersomes (PMs) consisting of PEG-PCL 
block copolymer (approved for clinical use) 
loaded with BIO 
BIO-loaded PMs for controlled 
activation of Wnt signaling and Runx2 
during osteogenesis 
Murine 3T3 Wnt reporter cells; Human 
BM-MSCs, osteogenic differentiation 
[181] 
None 
Local application of Wnt pathway 
modulators (BIO, CHIR, and Tegusib) 
to promote dentine regeneration 
Wistar rats and CD1 mice molar damage [121] 
BMP2 
Porous silica–calcium phosphate composite 
(SCPC50) (loaded with rhBMP2) 
Sustained release of fhBMP2 for 
alveolar ridge augmentation in saddle-
type defect 
Mongrel dog with induced mandible 
defect 
[182]  
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Calcium phosphate (Ca-P)/poly(L-lactic 
acid) (PLLA) nanocomposites loaded with 
rhBMP2 
3D Ca-P-PLLA scaffold sustainably 
releasing Ca2+ and rhBMP2 for 
enhanced osteogenesis 
Human BM-MSCs, osteogenic 
differentiation 
[183] 
Poly(lactic-co-glycolic acid)-multistage 
vector composite microspheres (PLGA-
MSV) (for BMP2 release) 
Controlled prolonged release of BMP2 
for osteoinduction of rat BM-MSCs 
Male SD rat BM-MSCs, osteogenic 
differentiation 
[184] 
TGF-β 1, 3 
Poly(ethylene oxide terephthalate)/ 
poly(butylene terephthalate) (PEOT/PBT) 
fibrous resins for loading the growth factors  
Sustained delivery of growth factors 
(TGF-β1, PDGF-ββ, IGF-1) using a layer 
by layer assembly for supporting 
fibroblast attachment and proliferation 
TK173 (human renal fibroblast cell line), 
neonatal rat dermal fibroblasts (nRDFs) 
[185] 
Poly(vinylidene fluoride) (PVDF) nanofibers 
fabricated via electro-spinning method 
with/without chitosan nanoparticles (loaded 
with TGF-β1) 
PVDF-TGF-β1 as a bio-functional 
scaffold for enhancing smooth muscle 
cells (SMC) differentiation 
AT-MSCs, SMC differentiation [186] 
Alginate nanogel with cross-junction 
microchannels (encapsulating TGF-β3) 
Controlled release of TGF-β3 from 
polymeric nanogel for enhanced 
chondrogenesis  
Human MSCs, chondrogenic 
differentiation 
[187] 
ATP, suramin (P2XR 
activators) 
Albumin nanoparticles (aNPs) of low 
polydispersity loaded with ATP and coated 
with erythrocyte membrane (EM)  
EM-aNPs developed as a delivery 
vehicle for ATP to be used as an 
anticancer agent 
HeLa, HEK-293 cell lines  [188] 
Hydroxyapatite (HA)/agarose hybrids for 
ATP and suramin release 
ATP and suramin release for hard 
tissue formation 
Release kinetic studies without cells (see 
Figure 4); biocompatibility test using AT-
MSCs and MG-63 cell line 
[171] 
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In detail, a sequential and on-demand release of multiple drugs (signaling molecules, activators, 
and suppressors) would be required to control and guide the signaling cascades of amelogenesis, 
odontogenesis, and cementogenesis [164]. Moreover, on-demand release systems usually require 
specific stimuli as reported for example for conductive polymer-based delivery devices [150]. Finally, 
theoretical modeling could provide a more fundamental understanding of release kinetics [189].  
4. Whole Tooth Regeneration 
The regeneration of a whole tooth as an organ replacement therapy is considered to be the 
ultimate goal of regenerative dentistry. For patients, this therapeutic option could represent a dream 
for the replacement of decayed or lost teeth to overcome prosthodontic or implantology treatment 
using artificial replacements. Whole-tooth generation could be performed as a hybrid strategy where, 
e.g., biologically created tissue compartments such as the periodontal ligament or a tooth crown 
would be combined with a metallic or ceramic implant or where a biological regenerated tooth root 
(“bio-root”) would be combined with a prosthetic crown (see, e.g., [190–192]). In the following years, 
efforts in creating a whole tooth from only cells and tissues (“bio-tooth”) will be very likely in the 
focus. However, despite all efforts and achieved results in basic and translational research, this 
approach is still challenging [48,58,69,193,194]. 
4.1. Reactivation the Odontogenic Potency 
On the background of teeth evolution, a genetic approach to generate whole teeth may be an 
option in the far future. Teethed fishes, reptiles, or amphibians are polyphyodonty, which means that 
several tooth generations can be formed and erupted. This highly regenerative capacity was reduced 
during evolution. In mammals, many species including human are only diphyodont with the 
capacity to form a second dentition or even monophyodont such as the mouse [71,72,195]. 
Revitalizing the odontogenic potency for the lost tooth regeneration capacity may be an interesting 
approach to induce tooth formation in vivo in the adult. One prerequisite for tooth replacement is 
the existence of a successional dental lamina (SDL) carrying the capacity for inducing odontogenesis. 
Even in monophyodont animals, rudimentary SDL has been identified. In addition, in the human 
species, rudimentary laminae are preserved, which might be responsible for a third dentition but this, 
however, has been observed very seldomly. On a molecular level, tooth replacement is regulated by 
signaling pathways [71]. For example, in alligators or snakes, stem cells in the SDL express Sox2, 
which is initiated by the Wnt/β-catenin pathway an interacts with BMP signaling [195]. Dysregulation 
of Wnt-signaling is discussed to be important for the de-activation of rudimentary SDL as it occurs 
in the mouse. Therefore, the revitalization by stabilizing Wnt signaling by application of appropriate 
factors or genes could be a strategy for the induction of re-growing teeth in the future [195,196]. 
4.2. Tissue Recombination Approaches 
The basic principle of this “classical” approach is to mimic the natural development and 
formation of a tooth and to recapitulate the signaling cascades regulating tissue interactions during 
odontogenesis. For over a hundred years, progress has been made in understanding tooth 
development in different species including human, identifying tissue interactions and factors 
involved on the morphological, cellular and molecular levels [18,58,65,71,193,195,197]. Classical 
tissue recombination experiments undertaken in developmental biology research have shown that 
mouse embryonic tooth germs can be dissociated and later re-aggregated. After temporary ectopic 
grafting of these cell aggregates, e.g., into the anterior eye chamber, subcutaneously, or under the 
renal capsule, tooth-like organs with mineralized tissues (dentin and enamel) could be grown (e.g., 
[198]). This method has been improved in the last years by using collagen drops for the organoid 
culture of 5–7 days or seeding the re-aggregated germ cells on biodegradable polymers [199–201]. 
The final goal of these experiments was to implant the constructs into the jaws of postnatal animals 
to generate a whole “bio-tooth”. In line with this cultured rat tooth, bud cells seeded onto 
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biodegradable scaffolds for 12 weeks formed tooth-like crowns consisting of pulp, dentin, enamel, 
and periodontal ligament after implantation into rat jaws [200].  
A breakthrough came with experiments of the group of Ikeda, who could demonstrate that the 
implantation of re-aggregated autogenous germ cells into the extraction socket of pigs succeeded in 
the formation, development, and eruption of teeth, which could be brought into occlusion and 
fulfilled all functions of normal teeth [50]. Over half (56%) of the implanted constructs had erupted. 
Later, it was also possible to create a unit of a regrown tooth with surrounding alveolar bone [202]. 
Whole-tooth restoration using autologous bioengineered tooth germ transplantation was also 
successful in canines [51]. An allogeneic approach was undertaken by Wu and colleagues, who 
transplanted re-associated tooth germs into the jawbones of minipigs [203]. A xenogeneic approach 
was published by Wang and co-workers in 2018 [52]. Cells from unerupted deciduous molar germs 
of pigs were recombined and transplanted first in mouse renal capsules and finally in jawbones. 
However, problems are caused by the limited sources of tooth germ cells and risks of immune 
rejection when using allogeneic or xenogeneic cells. In humans, there are many hindrances, e.g., that 
tooth germs may not be easily accessible, but also ethical and legal constraints must be considered. 
An alternative could be the use of adult stem cells (see Section 4.2) or of iPSCs [53,54].  
Different types of adult dental stem cells, e.g., from the pulp, or differentiated orofacial cells, 
e.g., from the gingiva, can be used as sources to create iPSCs with a similar epigenetic pattern. These 
cells show the ability to differentiate into epithelial or mesenchymal tooth germ cells [58,92]. Cai and 
co-workers generated iPS cells from cells out of human urine, which were differentiated to epithelial 
sheets and recombined with embryonic mouse dental mesenchyme [91]. Tooth-like structures were 
generated in which the epithelial cells differentiated into enamel-secreting ameloblasts. The 
formation of enamel, the hardest tissue of the body (see Section 2.2.1), is an important step in 
generating whole teeth, but also would be of importance for repair or regeneration of enamel loss in 
conservative dentistry. Thus, it is of major interest to find tissue sources able to generate dental 
epithelial cells which can be differentiated into enamel-secreting ameloblasts. Aside from iPSCs, 
examples for this are epithelial cells from the skin or gingiva as well as epithelial rests of Malassez, 
which can be found in the PDL, co-culture of these cells with different types of dental mesenchymal 
cells can lead to ameloblast differentiation or even formation of enamel-like structures [58,87,89]. 
4.3. Adult Stem Cell Approaches 
The optimal method to create whole teeth would be the use of autogenous dental cells from 
patients demanding tooth regeneration. For whole tooth bioengineering, different strategies in the 
application of these cells have been developed. One idea was to combine adult stem cells with cells 
of the progenitor cells of embryonic tooth. Adult stem cells should have an odontogenic competence 
and should function as a “tooth inducer” when combined with mesenchymal cells or they should 
express a dental mesenchymal competence when combined with dental epithelium. Already in 2002, 
Young et al. cultured cells obtained from unerupted porcine tooth buds [199]. The aggregates were 
grown on biodegradable scaffolds in vitro or transplanted. This led to the formation of a primitive 
tooth crown with pulp, dentin, and enamel formation. Later, similar bioengineered tooth-like 
structures could be obtained by using rat and human cells [204,205]. In 2004, Ohazama and colleagues 
used non-dental adult MSCs in combination with inductive embryonic dental epithelium first 
transplanted under the renal capsule and transplanted them in adult jaws. Tooth formation including 
root occurred and the teeth erupted. In addition, bone was induced [206]. Adipose-derived MSCs 
alone were able to generate tooth bud-like structures in vitro [90]. Human gingival epithelial cells 
were used by Volponi Angelova and associates and combined with embryonic mouse tooth 
mesenchyme, which yielded an entire tooth outside of an embryo [207].  
However, for all these experiments, relatively large amounts of adult cell populations were 
necessary that should be able to retain any odontogenic potential and, in addition, a large number of 
embryonic cells was needed as well. In a case of embryonic mouse tooth mesenchyme, a minimum 
cell number of 4 × 104 to 4 × 105 was sufficient according to the experiments of Hu et al. (2006) [208]. 
Therefore, to do so, cells from multiple embryos must be harvested. Another problem is the loss of 
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the inductive capacity already after 24–48 h in culture, which makes the in vitro expansion of these 
cells using standard methods impossible [209]. This phenomenon can be explained by the fact that 
mesenchymal stem cells lose their dense packaging formed by cellular condensation and thus their 
linked cell contacts, which is a prerequisite for an inductive capacity in vivo. Ongoing research 
focuses therefore also on how an odontogenic potential can be maintained in vitro [194]. 3D micro-
culture systems such as the hanging drop method in liquid media may allow the preservation of such 
signals. However, many cells are necessary for these methods [210]. Gene expression studies must be 
undertaken to identify signaling factors, which are lost in 2D cell cultures. In a study using postnatal 
dental pulp stem cells, Yang and collaborators could obtain “a rescue” in cultured cells due to the 
combination with uncultured mesenchymal tooth germ cells [57]. This rescue or community effect is 
responsible for the reactivation of inductive signals. Forthcoming, iPS cells (see Section 4.2) may be 
an appropriate cell substitute to overcome these biological problems.  
In the future, research will presumably focus on using adult stem cells from dental and non-
dental sources to test recombination or co-culturing for their effects on tooth development. Zhang 
and coworkers optimized such a method by recombinant 3D-tissue engineering of intact dental 
tissues and cell suspensions from postnatal porcine teeth and human third molars [211]. After 
osteogenic culturing and subcutaneous transplantation in athymic nude rat hosts, tooth-like 
constructs forming all dental hard substances could be harvested. Recently, tooth buds could be 
generated by co-culturing postnatal dental stem cells with human HUVEC cells encapsulated in 
gelatine hydrogel [56]. Only postnatal dental stem cells were used by Yang et al. (2016), who 
differentiated odontoblasts and osteoblasts from pig dental pulp stem cells and seeded them with 
gingival epithelium on a bioactive scaffold. Implantation into extraction sockets of 13.5-month-old 
pigs revealed the development of teeth in seven of eight animals. The regenerated molar teeth 
expressed dentin-matrix protein-1 and osteopontin [212].  
4.4. Problems in Whole Tooth Regeneration 
Despite the progress in some basic strategies for tooth regeneration, we still face a lot of problems 
[18,48]. An important condition for a proper functional occlusion in a dentition where teeth should 
be replaced by regeneration is the correct anatomical size and shape of the crown. Especially the relief 
of the occlusal surface with its specific pattern of fissures and cusps is relevant for a functional 
occlusion. The proper size and shape of a crown are determined by epithelial morphogenesis forming 
spatially regulated cellular condensations as signaling centers, called knots [71,197]. These knots 
(initiation knot, primary enamel knot, and secondary enamel knot) regulate crown development and 
cusp number, morphology, and pattern by expressing different factors such as FGF, BMP, Wnt, or 
Shh, as already mentioned. The number of tooth cusps in the mouse depends on the activity of Shh, 
EDA, and Activin A pathways [71,197]. The tooth size is independently regulated from the cusp 
number and is not only dependent on epithelial, but also mesenchymal influences. Therefore, it was 
suggested that the tooth size could be controlled by prolonging the activity of tooth epithelial stem 
cells and increasing the number of mesenchymal stem cells in recombination experiments [197]. The 
different tooth types such as molars or incisors have specific morphological features not only of the 
occlusal surface but also of the crown and root morphology. This will also be an important aspect for 
future tooth engineering [193]. The quality and the biomechanical loading of dental hard tissues are 
also important for occlusion and mastication. In already developed models of tooth regeneration, 
only a low level of enamel mineralization could be observed.  
Tooth health is also dependent on proper vascularization and innervation. While vascularization 
occurs in different models already published [213], the question is whether this would be also 
sufficient for the long-lasting survival of regenerated teeth. Efforts have been made to induce 
neurogenesis and formation of nerve fibers, e.g., by using exogenous agents such as semaphorin 3 
receptor inhibitors, by application of immunomodulation using cyclosporin A, or implication of bone 
marrow stromal cells [48]. Recently, Strub et al. recombined embryonic dental epithelium with a 
mixture of dental mesenchymal cells and bone marrow-derived cells and cultured and implanted 
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these cells subcutaneously. The tooth-like tissues obtained were innervated with axons entering the 
newly formed pulp [214].  
Other problems include the formation of a proper periodontium or infections occurring during 
or after transplantation. If whole tooth constructs can be implanted, the role of the tissue environment 
will play an important role in the success: How is the quality of the jawbone? How will the 
implantation be affected by age or systemic diseases of the patients? How resistant will the newly 
created tooth be against probable infections? Finally, the costs of creating a “bio-tooth” are also 
unpredictable yet [48,156]. 
5. Conclusions and Future Perspectives 
Progress in regenerating whole teeth will need scientific research on different levels such as 
identification of appropriate cell sources with tooth inductive signals. For this further research on the 
feasibility of iPS cells for this approach is important. Furthermore, the identification of master genes 
in gene regulatory networks responsible for tooth induction and tooth formation is necessary for 
successful manipulation of, e.g., adult cells to form bioengineered dental tissues, and to control tooth 
crown, size and tooth identity.  
Applying the acquired knowledge about signaling pathways shaping dental tissue genesis 
might stimulate novel cell culture techniques establishment and functionalized scaffolds 
development. Functionalized biomaterials will presumably play a central role in hard dental tissue 
regeneration such as dentin and cementum and probably the main role in enamel regeneration since 
this tissue is acellular and cannot be reproduced in vitro relying solely on a cell-based approach. 
Although several potentially appropriate biomaterials have already been investigated and tested, 
only very few examples were used in clinical studies until now. Future efforts in stem cell-based 
approaches will very likely be directed toward biomaterials that allow sequential and on-demand 
drug release of multiple drugs in order to tailor timely the different cascade processes during 
amelogenesis, dentinogenesis, and cementogenesis, respectively.  
On the translational level, methods to improve 3D organogenesis, 3D printing applications, or 
the appropriate application of stimulatory molecules and drugs should be tested intensively. 
Solutions must be found for the proper mineralization of dental hard tissue formed by the 
regeneration process to ensure the natural properties of teeth in occlusion and mastication. Finally, 
there are considerable financial investment problems that should be taken into account. Then, but 
only then, whole biological tooth regeneration may even be a blueprint for the regeneration of other 
complex organs [70].  
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